Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 04, 2020
JanOne has confirmed stability of its developmental batch run of JAN101.
read more
Monday, September 07, 2020
Nutriband has completed the acquisition of Pocono Coated Product's Transdermal and Health product manufacturing business effective August 31, 2020.
read more
Monday, September 07, 2020
PAI announced the company has been awarded a three-year contract from HealthTrust Purchasing Group as a supplier of pharmaceutical products to its Membership nationwide.
read more
Monday, September 07, 2020
PPD and LT have entered into a collaboration to expand and enhance lupus clinical research for PPD’s pharmaceutical and biotech customers.
read more
Tuesday, September 08, 2020
AMRI has signed a supply agreement with AstraZeneca to support the manufacture of AstraZeneca’s COVID-19 vaccine candidate AZD1222.
read more
Tuesday, September 08, 2020
Mylan announced an agreement to acquire the related intellectual property and commercialization rights of Aspen's thrombosis business in Europe.
read more
Wednesday, September 09, 2020
Brickell has the right to develop AnGes’ proprietary investigational adjuvanted plasmid DNA vaccine intended to prevent COVID-19.
read more
Thursday, September 10, 2020
NKMax America has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate the safety and tolerability of SNK01.
read more
Monday, September 14, 2020
MilliporeSigma announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin.
read more
Monday, September 14, 2020
Rockwell Medical has entered into an exclusive license agreement with Jeil for the rights to commercialize Triferic in South Korea.
read more
Tuesday, September 15, 2020
Cobra Biologics and CombiGene have signed agreements covering GMP production of two essential plasmids needed for the manufacture of a gene therapy for drug resistant focal epilepsy.
read more
Wednesday, September 16, 2020
Sai Life Sciences announced the addition of cellular analysis platforms at its Discovery Biology facility in Cambridge, Massachusetts, USA.
read more
Wednesday, September 16, 2020
The FDA has issued a temporary guidance, “Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency.”
read more
Wednesday, September 16, 2020
Valneva and Dynavax announced a commercial partnership for the supply of Dynavax's CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001.
read more
Monday, September 21, 2020
Alimera Sciences Europe has signed a distribution agreement with Medis for the exclusive sales and distribution of ILUVIEN in the Czech Republic and Austria.
read more